Wilson Sonsini is proud to sponsor the Pharmaceutical & BioScience Society (PBSS).

This symposium, "Discovery and Development of Orally Bioavailable Peptides from Concept to Clinic: Structural Design, Formulation Development, Translational Science, and IP Issues," addresses the differentiating advantages of peptide drugs, such as high target specificity and favorable safety profiles, alongside significant challenges like limited GI permeability and poor bioavailability.

This symposium addresses key issues associated with achieving peptide oral bioavailability:

• Criteria for orally bioavailable peptides – what properties enhance the potential for oral bioavailability?
  • How peptides are evaluated to determine these properties – in vitro, ex vivo, in vivo
• Structural modification of peptides to enhance oral bioavailability
• Formulation approaches to peptides to enhance oral bioavailability
  • Penetration enhancers
  • AI/ML/lab automation to identify and optimize excipient blends for oral peptide formulations
• Intellectual property issues related to discovery and development of oral peptides – composition of matter, formulation, use, etc
• Integrated discovery and development of oral peptides, from concept to clinic
• Case studies

Visit the event website to register and learn more.